Rehman Obaid, Sackfield Bradley, Thoguluva Chandrasekar Viveksandeep, Oliver Jorge, Aswath Ganesh
Internal Medicine, Hamilton Medical Center, Dalton, USA.
Gastroenterology, Mayo Clinic in Arizona, Phoenix, USA.
Cureus. 2022 Feb 26;14(2):e22631. doi: 10.7759/cureus.22631. eCollection 2022 Feb.
Cholangiocarcinoma (CCA) is a major cause of primary liver carcinoma and has been associated with the penetrance of several germline mutations. We present a 31-year-old female evaluated for left upper quadrant pain and abnormal liver function tests. Ultrasound revealed a nodule in the liver, and biopsy showed intrahepatic adenocarcinoma. Germline testing was positive for two mutations: c.1100delC and c.1227_1228dupGG on the CHEK2 gene and the MUTYH gene, respectively. The patient was started on chemotherapy and tolerated it well. We aimed to demonstrate an association between CHEK2 and MUTYH mutations with CCA and highlight the importance of genetic testing for at-risk patients.
胆管癌(CCA)是原发性肝癌的主要病因,并且与几种种系突变的外显率有关。我们报告一名31岁女性,因左上腹疼痛和肝功能检查异常前来就诊。超声检查发现肝脏有一个结节,活检显示为肝内腺癌。种系检测发现两个突变呈阳性,分别是CHEK2基因上的c.1100delC和MUTYH基因上的c.1227_1228dupGG。患者开始接受化疗,耐受性良好。我们旨在证明CHEK2和MUTYH突变与CCA之间的关联,并强调对高危患者进行基因检测的重要性。